ImmuCell Corp (ICCC)
5.42
+0.13
(+2.46%)
USD |
NASDAQ |
May 10, 16:00
5.42
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Shareholders Equity (Quarterly): 24.99M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 24.99M |
September 30, 2023 | 26.01M |
June 30, 2023 | 26.86M |
March 31, 2023 | 28.16M |
December 31, 2022 | 30.38M |
September 30, 2022 | 31.98M |
June 30, 2022 | 32.77M |
March 31, 2022 | 33.37M |
December 31, 2021 | 32.58M |
September 30, 2021 | 32.46M |
June 30, 2021 | 32.27M |
March 31, 2021 | 27.87M |
December 31, 2020 | 28.27M |
September 30, 2020 | 28.02M |
June 30, 2020 | 28.28M |
March 31, 2020 | 28.99M |
December 31, 2019 | 28.99M |
September 30, 2019 | 29.19M |
June 30, 2019 | 29.64M |
March 31, 2019 | 30.25M |
December 31, 2018 | 21.74M |
September 30, 2018 | 22.67M |
June 30, 2018 | 22.81M |
March 31, 2018 | 23.49M |
December 31, 2017 | 23.59M |
Date | Value |
---|---|
September 30, 2017 | 20.95M |
June 30, 2017 | 20.20M |
March 31, 2017 | 20.37M |
December 31, 2016 | 19.72M |
September 30, 2016 | 16.41M |
June 30, 2016 | 16.31M |
March 31, 2016 | 16.32M |
December 31, 2015 | 10.61M |
September 30, 2015 | 10.30M |
June 30, 2015 | 9.904M |
March 31, 2015 | 9.743M |
December 31, 2014 | 9.258M |
September 30, 2014 | 9.124M |
June 30, 2014 | 9.103M |
March 31, 2014 | 9.392M |
December 31, 2013 | 9.396M |
September 30, 2013 | 9.511M |
June 30, 2013 | 9.446M |
March 31, 2013 | 9.413M |
December 31, 2012 | 9.195M |
September 30, 2012 | 9.199M |
June 30, 2012 | 9.258M |
March 31, 2012 | 9.247M |
December 31, 2011 | 9.020M |
September 30, 2011 | 8.994M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
24.99M
Minimum
Dec 2023
33.37M
Maximum
Mar 2022
29.53M
Average
28.99M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 43.81M |
Total Liabilities (Quarterly) | 18.82M |
Debt to Equity Ratio | 0.4789 |
Current Ratio | 2.733 |
Net Debt Paydown Yield | -0.76% |